Shares of Wave Life Sciences Ltd. (WVE) are gaining more than 34 percent on Wednesday morning after reporting narrower net loss in fourth-quarter.
The company revealed loss of $16.25 million or $0.15 per share compared to loss $43.70 million or $0.47 per share in previous year quarter.
Analysts, on average, had estimated loss of $0.23 per share for the same quarter.
Currently, Wave's stock is surging 34.66 percent, to $6.45 over previous close of $4.79 on a volume of around 3.1 million.
The company's revenue increased to $29.05 million from $1.2 million last year due to collaborations with GSK and Takeda.
For comments and feedback contact: editorial@rttnews.com
Business News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.